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Abstract
The molecular basis of pathogen-induced host cell apoptosis is well characterized for a number of microorganisms.
Mycobacterium tuberculosis is known to induce apoptosis and it was shown that live but not heat killed M. tuberculosis
stimulates this biological pathway in monocytes. The dependence of this activity on live bacilli led us to hypothesize that
products released or secreted by M. tuberculosis are the primary apoptotic factors for human monocytes. Thus, the culture
filtrate of in vitro grown M. tuberculosis strain H37Rv was fractioned by conventional chromatography and the apoptosis-
inducing activity of individual fractions was measured on human monocytes. The tests employed included measurement of
cell membrane damage, caspase activation, and cytokine release. Small molecular weight RNAs of M. tuberculosis were
recognized as the predominant apoptosis inducing factors. The RNA was comprised primarily of tRNA and rRNA fragments
that stably accumulate in the culture filtrate during early log-phase growth. The RNA fragments signaled through a caspase-
8 dependent, caspase-1 and TNF-a independent pathway that ultimately compromised the human monocytes’ ability to
control M. tuberculosis infection. These studies provide the first report of bacterial RNA inducing apoptosis. They also
provide a foundation to pursue pathways for secretion or release of nucleic acids from M. tuberculosis and the impact of
secreted RNA fragments on pathogenesis.
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Introduction
Apoptosis mainly occurs following activation of the caspase
cascade by the mitochondrial or apical pathways [1,2]. Mito-
chondrial release of organelle constituents such as cytochrome c
and other macromolecules [3], activates the caspase cascade via
pro-caspase-9. Alternatively the apical pathway is mediated by
activation of pro-caspase-8 after cross linking of cell surface
receptors belonging to the Tumor Necrosis Factor Receptor
(TNFR) super family [4]. Both pathways converge to activate the
executioner caspase-3 [1,3]. Other alternative pathways designat-
ed as ‘‘type II’’ that do not rely on caspase 3 activity were
described recently [5]. Cell death ensues after cleavage of the cell’s
cytoskeleton and intracellular enzymes involved in cellular
homeostasis, leading to apoptosis hallmarks such as exposure of
phosphatidylserine (PS) in the cell membrane, DNA fragmenta-
tion, and cell shrinkage [1,2].
Apoptosis is a process associated with multiple infectious diseases
including tuberculosis [6]. Several lines of evidence suggest that
apoptosis is an important process occurring during mycobacterial
infection [7]. Recently, caspase activation and TUNEL staining
demonstrated that apoptosis is a major event occurring in the
caseous necrosis of granulomas from M. tuberculosis-infected humans
[8]. More importantly, sst-1 and slca11 (formerly nramp-1), the best
characterized murine genetic loci determining susceptibility/
resistance to mycobacterial infections, were associated with the
degree of macrophage apoptosis [9–11]. It also is known that
macrophage infection with live M. tuberculosis or stimulation with
PPD activate both the apical and mitochondrial apoptotic pathways
by inducing TNF-a production, caspase activation and calcium
influx, [11–15]. In contrast dead M. tuberculosis and lipoarabino-
mannan (ManLAM) inhibit these pathways by inducing IL-10,
activating Akt and blocking calcium influx [14–18].
Several mycobacterial molecules of diverse chemical nature
were reported to induce apoptosis in various types of host cells. In
particular, the 19 kilodalton (kDa) lipoprotein was shown to
trigger murine and human macrophages apoptosis through TLR-2
via nitric oxide dependent and independent pathways [19–22].
Glycolipids such as trehalose dimycolate (TDM) and lipomannan
(LM) from M. tuberculosis also activate apoptosis [23–25]. TDM
induces apoptosis of murine natural killer and naı ¨ve T cells
[23,24], while LM targets human macrophages [25]. Contrary to
the consistent finding that macrophage apoptosis requires infection
with live, metabolically active mycobacteria [11], the aforemen-
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purified from inactivated cells. However, a systematic purification
of secreted products released by actively growing M. tuberculosis
that promote apoptosis has not been performed.
To further address this issue we purified the major apoptosis-
inducing product released by virulent M. tuberculosis strain H37Rv,
and unexpectedly discovered this primary apoptotic factor was
stable mycobacterial RNA fragments and not a protein or lipid.
Additional experimentation revealed the nature of these stable
RNA molecules and that their induction of apoptosis was via a
caspase-8 dependent, and TNF-a and caspase-1 independent
mechanism that affected the ability of human monocytes to
control mycobacterial infection.
Results
Purification and identification of apoptosis inducer
Infection of human derived monocytes for 48 h with live,
virulent M. tuberculosis (MOI of 5:1) induces early apoptotic events
that are defined by annexinV positive and propidium iodide
negative staining [12]. However, apoptosis does not occur with
formaldehyde-fixed or heat-killed M. tuberculosis. Thus, it was
hypothesized that induction of apoptosis in human monocytes was
due to a secreted product of M. tuberculosis [11]. Towards purifying
the responsible mycobacterial product(s), the CF from in vitro
cultures of M. tuberculosis H37Rv was shown to induce monocyte
cell membrane damage similar to the live infection (Fig. 1A) [12].
As a first step in the purification scheme the ManLAM, previously
shown to inhibit macrophage apoptosis [15,17,18], was removed
by ConcanavalinA-affinity chromatography to give Man-LAM
depleted CF (CF-Man). This material was further resolved on
DEAE-Sephadex with a stepwise gradient of sodium chloride from
0–1000 mM, resulting in seven fractions (Fig. 1B). Evaluation of
each fraction for induction of apoptosis via annexinV staining,
demonstrated that fraction 7 induced the strongest response with
nearly 70% of human monocytes displaying early cell membrane
damage (Fig. 1A) (a small percentage of cells was dually labeled
with annexinV and propidium iodide, data not shown). Removal
of ManLAM by ConA chromatography consistently reduced the
biological activity of CF (Fig. 1A), but this reduction was not
statistically significant (p.0.05). In addition to binding ManLAM,
ConA chromatography could also be retaining mannosylated
molecules such as LM and the 19 kDa lipoprotein, which are
known to induce apoptosis [19,20,25]. Considerable activity was
also associated with fraction 5 and 6. However, further purification
and characterization was targeted to fraction 7 as it was the most
potent.
The chemical nature of the apoptotic-inducing mycobacterial
molecule(s) present in fraction 7 was initially determined by
assessing the loss of stimulation after differential enzymatic
digestion with Proteinase K, DNaseI, or RNaseV1 (Fig. 2A).
Unexpectedly, the apoptosis-inducing activity of fraction 7 was
completely abrogated by treatment with RNaseV1, as there was a
95% reduction in the number of annexinV positive cells. Digestion
with DNaseI had no impact, whereas Proteinase K treatment
increased the number of monocytes in early apoptosis (80% of
monocytes), but was not statistically significant. Treatment of
monocytes with enzymes alone had a negligible effect on apoptosis
(data not shown). Evaluation of fraction 7 by SDS-PAGE and
ethidium bromide or silver staining pre and post enzymatic
digestions (Fig. 2B and C) confirmed the presence of nucleic acids
in fraction 7. These nucleic acids migrated at ,20 kDa by SDS-
PAGE and were only eliminated by digestion with RNaseV1
(Fig. 2B). It was also noted that Proteinase K, but not RNaseV1 or
DNaseI treatment resulted in the elimination of proteins present in
fraction 7. Furthermore, RNaseV1 treatment was additionally
performed on CF and CF-Man to determine the RNA’s
contribution to monocyte cell membrane damage induced by these
complex fractions. As determined by evaluating the samples pre-
and post-RNaseV1 digestion, the RNA was responsible for almost
70 and 90% of the biological activity from CF and CF-Man,
respectively(Fig.2A).Incubationwith1 mg/mlofCFwouldcontain
approximately 30 ng of RNA, (Sheldon and Belisle, unpublished
results), highlighting the biological potency of this product.
Definition of Biologically Active RNA
To confirm that RNA was responsible for the biological activity,
fraction 7 was digested with DNaseI and Proteinase K, extracted
with phenol/chloroform/isoamyl alcohol (25:24:1) to remove
contaminating lipids and undigested proteins and the resulting
RNA was gel purified from a denaturing urea-polyacrylamide gel
(Fig. 3A). Gel purified RNA was subjected to RNaseV1 treatment
and compared to untreated RNA in the biological assay with
human monocytes. The apototic activity of the gel purified RNA
was retained after purification (72% apoptotic monocytes), and
this activity was abrogated by RNaseV1 treatment (7.5% apoptotic
monocytes) (Fig. 3A and B). As a control to ensure RNaseV1 was
not modulating monocyte apoptosis via a different mechanism, we
evaluated cell membrane damage induced by the well character-
ized anti-CD95 pathway in the presence or absence of RNaseV1.
No difference in AnnexinV positive cells was observed when
monocytes were co-incubated with anti-CD95 and RNaseV1
versus anti-CD95 alone (Fig. 3B). Finally, to evaluate whether
monocyte cell membrane damage could be induced by other
sources of exogenous RNA, monocytes were incubated with rabbit
mRNA; no induction of monocyte apoptosis was observed
(Fig. 3B). These results confirmed that fraction 7 obtained from
M. tuberculosis H37Rv CF is enriched in RNA, which was the sole
inducer of human monocytes cell membrane damage.
To further define the RNA present in the CF the same strategy
utilized to clone siRNA was adopted [26,27]. From a library of
cDNA clones plasmids were purified from a total of 33 clones.
Sequence analyses of the plasmid inserts revealed that the M.
tuberculosis RNA present in the CF predominantly consisted of
tRNA and rRNA with lengths between 30 to 70 bases (Table 1).
Of the 17 tRNA sequences, a majority corresponded to tRNA
Asp
fragments and a total of 15 clones represented 16S or 23S rRNA
fragments, indicating selectivity in the RNA species released into
the CF. Sequence alignments for both the 16S and 23S rRNA
showed that the majority of fragments originated from different
regions of the mature rRNA and only occasionally did two
fragments correspond to the same region (Fig. S1, upper and
middle panel). Alignment of the cloned tRNA fragments
determined that they were truncated at both the 59 and 39 ends
(Fig. S1, lower panel).
Kinetics of RNA Release
As tRNA and rRNA are highly abundant intracellular
constituents, kinetic studies were performed to evaluate when
the M. tuberculosis RNA started to accumulate in the CF and if its
presence was attributable to the CF being harvested from late
logarithmic (14 day), presumably autolytic, cultures. After
extensively washing cells with GAS medium, CF was collected at
different time points (0 to 28 days) and analyzed by SDS-PAGE
and ethidium bromide staining. Interestingly, the presence of M.
tuberculosis RNA paralleled M. tuberculosis protein secretion into the
CF. Specifically, the RNA began to accumulate between two and
three days of culture (early log phase), becoming more abundant as
Induction of Apoptosis by M. tuberculosis RNA
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when the CF was immediately precipitated with acetone after
harvesting, to rule out the possibility that higher molecular weight
RNA species were being degraded to 30 to 70 bases during the
protracted processing of CF (not shown). These results suggest that
in addition to secreted proteins, M. tuberculosis H37Rv actively
releases rRNA and tRNAs into the CF and these accumulate as
stable products starting in early log phase.
Mechanism of RNA Induced Apoptosis
In order to assess the mechanism by which RNA induced
apoptosis, TNF-a and IL-10 production was evaluated since the
balance between these two cytokines is a factor in modulating cell
death [12–14,16]. M. tuberculosis RNA induced the intracellular
production of these two cytokines to a level similar to that induced
by the positive control, PPD (Fig. 4A). However, in contrast to
PPD, the cell membrane alterations induced by RNA were not
blocked with anti-TNF-a (Fig. 4B).
Given the importance of caspase activity in TNF-a dependent
and independent apoptotic pathways [1,4], and recent reports that
bacterial RNA activates caspase-1 [28], experiments were
performed to determine whether M. tuberculosis H37Rv RNA
activates caspases. M. tuberculosis RNA strongly activated caspase-8
(LETD-FMK), intermediately activated caspase-3 (DEVD-FMK)
Figure 1. Separation of CF by ConA affinity chromatography and DEAE-Sepharose chromatography yielded a fraction with potent
apoptotic activity in human monocytes. A. Apoptosis induced by DEAE-Sepharose fractions 1 to 7 (F1 to F7) and unfractionated CF was
measured by flow cytometry and presented as percentage of human monocytes that stained annexinV positive *** significance p,0.001,
** significance p,0.01, * significance p,0.05 as compared to unstimulated control. B. SDS-PAGE and silver staining of fractions of CF after ConA
affinity (CF-Man) and DEAE-Sepharose chromatography (F1 to F7). Mw denotes the molecular mass standards.
doi:10.1371/journal.pone.0029970.g001
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mined by flow cytometry (Fig. 5A). In contrast, PPD activated
caspase-1, 3 and 8 to similar extents. Consistent with these data,
only caspase-8 inhibitor abrogated the RNA induced cell
membrane alterations, whereas all the caspase inhibitors signifi-
cantly abrogated PPD’s activity (Fig. 5B). These findings provide
evidence that M. tuberculosis RNA activates apoptosis via a caspase-
8 signaling mechanism and that this route of activation differs
from those observed for other mycobacterial products [12].
Lastly, the ability of RNA to alter monocyte’s control of
mycobacterial growth was examined by treating M. tuberculosis
infected human monocytes with purified RNA. Determination of
colony forming units (CFUs) after four days of incubation revealed
a greater than two fold increase in the number of bacilli associated
with RNA treated vs. untreated monocyte cultures (Fig. 6).
Furthermore, digestion with RNaseV1 abrogated the RNA’s
deleterious effect on monocyte control.
Discussion
Understanding apoptosis at a molecular level is critical to
elucidating the pathogenesis of tuberculosis. Recent in vivo
evidence suggests that apoptosis is an active mechanism in
necrotic granulomas [8], a pathological hallmark of tuberculosis
that is widely accepted as being key to the bacterium’s persistence
and transmission [29]. Our search for a M. tuberculosis product that
replicated the apoptotic activity observed with a live M. tuberculosis
infection [11], led to the surprising discoveries firstly that low
molecular weight RNA fragments were secreted into the CF, long
known as a source of major M. tuberculosis protein antigens, and
secondly that these RNA fragments were major apoptotic factors.
Figure 2. RNA in DEAE-Sepharose Fraction 7 induces apoptosis in human monocytes. A. Apoptosis induced by DEAE-Sepharose Fraction 7
(F7), F7 treated with proteinase K (F7+ProtK), F7 treated with DNase1 (F7+DNase1), F7 treated with RNaseV1 (F7+RNaseV1), CF, CF treated with
RNaseV1 (CF+RNaseV1), CF-Man, CF-Man treated with RNaseV1 (CF-Man+RNaseV1). Apoptosis was measured by flow cytometry and presented as
percentage of human monocytes that stained annexinV positive. *** significance p,0.001, ** significance p,0.01 as compared to unstimulated
control or between treated samples. B. SDS-PAGE with ethidum bromide staining and C. silver staining of F7 and F7 treated with proteinase K,
DNase1, or RNaseV1.
doi:10.1371/journal.pone.0029970.g002
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was initially proposed by Youmans and colleagues in the 1960s
and 70s [30,31]. In their studies, ribosomal RNA obtained from
whole cells increased bacterial burden when introduced into
infected animals. Our experiments demonstrated that apoptosis
induced by RNA significantly altered the ability of the monocytes
to control M. tuberculosis growth. Although these studies did not
assess in vivo growth of M. tuberculosis in a manner similar to
Youmans and colleagues, they do provide support and a potential
explanation for the early observations.
The activation of specific caspases is central to the induction of
apoptosis and classically differentiates between the mitochondrial
and apical pathways [1,5]. The strong induction of caspase-8
activity with the M. tuberculosis RNA fragments and the prevention
of apoptosis with a caspase-8 inhibitor provided convincing
evidence for the induction of apoptosis via the apical pathway.
The M. tuberculosis RNA fragments also stimulated the production
of TNF-a and although TNF-a is primarily recognized as a
mediator of inflammation, it can also induce apoptosis via caspase-
8 when it binds to the TNF-R1 [4,5]. However, anti-TNF-a
antibodies did not inhibit the induction of apoptosis by M.
tuberculosis RNA fragments. Similar to what has been reported
during macrophage infection with virulent M. tuberculosis [32], it is
possible that mycobacterial RNA induces TNF-R2 shedding thus
rendering monocytes unresponsive to TNF-a. Our previous work
as well as that of others also indicated a potential role for caspase-1
in M. tuberculosis mediated apoptosis [14,15]; however, the current
studies demonstrated that M. tuberculosis RNA induction of
apoptosis was caspase-1 independent. This lack of caspase-1
involvement also suggests that the M. tuberculosis RNA is not
inducing an inflammasome response [33]. We did not, however,
investigate whether the RNA fragments inhibited caspase-1
Figure 3. Human monocyte apoptosis is specifically induced by gel-purified mycobacterial RNA. A. SDS-PAGE with ethidium bromide
(left) and silver stained (right) gel-purified RNA (gpRNA) from F7 and treated with RNaseV1 (gpRNA+RNaseV1). B. Monocyte apoptosis induced by
gpRNA untreated or treated with RNaseV1, anti-CD95 untreated or treated with RNaseV1 (anti-CD95+RNaseV1) and rabbit mRNA. Significance as
described above.
doi:10.1371/journal.pone.0029970.g003
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infections [34]. In the apical pathway of apoptosis, caspase-3 is
defined as the effector caspase and is downstream of caspase-8
[1,5]. Our studies unexpectedly revealed that treatment of
monocytes with M. tuberculosis RNA fragments only resulted in a
modest increase in caspase-3 activity, as compared to that induced
by PPD, and inhibition of caspase-3 failed to prevent M. tuberculosis
RNA induced apoptosis. Thus, while the caspase-8 data suggest
that the excreted M. tuberculosis RNA fragments stimulate
monocyte apoptosis via the apical pathway, the non-essentiality
of TNF-a or caspase-3 indicated an alternative mechanism of
induction. One potential mechanism is that described for the ‘‘type
II’’ apoptotic cells where capase-8 activation directly induces a
mitochondrial pathway of apoptosis and is associated with FAS or
TNF-related apoptosis-inducing ligand (TRAIL) mediated signal-
ing [5]. Our studies provide additional experimental evidence to
the increasing observations that caspase-8 plays a critical role not
only during in vitro experiments with mycobacteria-infected
macrophages but also in patients with active disease [35,36].
Future work will assess the specific apoptotic pathway and
signaling events stimulated by excreted M. tuberculosis RNA.
The RNA fragments characterized in this study possess
numerous dsRNA hairpin structures, and studies with other viral
and bacterial dsRNAs demonstrate that interactions with TLR-8
or cryopyrin led to caspase activation [28,37,38]. Interactions
between dsRNA and TLR-8 result in caspase-8 activity [37,38]
and TLR-8 polymorphisms are associated with increased
susceptibility to tuberculosis [39]. Thus, activation of host
monocytes via TLR8 would fit the data presented for the M.
tuberculosis RNA fragments. In contrast, bacterial RNA interactions
with cryopyrin activate caspase-1 [28], an event that did not occur
with the M. tuberculosis RNA fragments. It must also be considered
that tRNA and rRNA undergo multiple species-specific modifica-
tions [40,41] that could alter their ability to activate different
pattern recognition receptors (PRRs) and signaling pathways. In
contrast, mammalian mRNA, which is known to possess different
modifications [41], did not activate monocyte apoptosis as the
mycobacterial RNA fragments. Therefore, other PRRs for the M.
tuberculosis RNA fragments need to be considered in future studies
such as Protein Kinase R (PKR) that is activated in macrophages
infected with M. bovis BCG [42], the endosomal TLR-3 and TLR-
7 [43,44], and cytoplasmic receptors Rig-1, MDA-5, DAI and
Nod [45]. The stability of the M. tuberculosis RNA fragments must
also be considered with respect to accumulation within the host.
The complex secondary structure of the tRNA and rRNA might
protect against host as well as bacterial RNase activity, and allow
for its stable accumulation in the granuloma.
Multiple classes of pathogen derived macromolecules are
defined as modulators of innate immunity, including RNA and
DNA [46]. However bacterial nucleic acids typically are not
Table 1. Sequence analysis of cloned extracellular
mycobacterial RNA fragments present in M. tuberculosis CF.
Cloned RNA Number of Clones
2
tRNA
Asp1 10
tRNA
Asn 4
tRNA
Lys 1
tRNA
Thr 2
23S rRNA
1 9
16S rRNA
1 6
mRNA 1
1The specific regions of the RNA sequences represented by each clone are
depicted in Figure S1.
2The number of clones represents the total number of sequences observed for
each RNA species.
doi:10.1371/journal.pone.0029970.t001
Figure 4. Human monocyte apoptosis induced by extracellular M. tuberculosis H37Rv RNA is TNF-a independent. A. TNF-a (open bars)
and IL-10 (closed bars) induced in human monocytes treated with DEAE-Sepharose Fractions 7 (F7), gel purified M. tuberculosis H37Rv (gpRNA) and
purified protein derivative (PPD) from M. tuberculosis were measured by flow cytometry and the data presented as the percentage of human
monocytes producing the cytokine, *** significance p,0.001 as compared to unstimulated control. B. Human monocytes were incubated with
gpRNA, F7 or PPD, and annexinV staining was measured by flow cytometry (open histogram with dotted line) to assess apoptosis. Treatment of
monocytes with anti-TNF-a for 1 h prior to stimulation with F7, gpRNA, or PPD demonstrated no alteration in annexinV staining for monocytes
incubated with F7 or gpRNA, but did result in decreased annexinV staining for monocytes incubated with PPD (closed histogram). The open
histograms with a solid line correspond to unstimulated monocytes.
doi:10.1371/journal.pone.0029970.g004
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small RNA fragments from the CF of M. tuberculosis as the primary
apoptotic factor was unexpected. The possibility that release of
RNA fragments is due to lysis of M. tuberculosis was investigated by
following the kinetics of RNA release. Such analyses revealed that
accumulation of the secreted RNA fragments paralleled the
kinetics of M. tuberculosis protein secretion. RNA was observed in
the CF as early as 2 days, the same point in time used to
distinguish truly secreted proteins from those resulting from
autolysis [47]. Additionally, there did not appear to be a massive
accumulation of extracellular RNA during late log-phase that
would imply cell lysis as the underlying mechanism. Although a
specific mechanism of active transport of the RNA fragments was
not identified, there are suggestions by others that the ESX (Type
VII) secretion apparatus of Mycobacterium spp. is involved in DNA
transfer or conjugation [48]. There are multiple ESX like secretion
modules encoded on the M. tuberculosis genome [49] and
investigation into whether one or more of these is involved in
secretion of the RNA fragments is on-going. Our current data does
not completely rule out that early bacterial lysis or cell division
contributed to RNA release. It is well known that other
intracellular molecules such as heat shock proteins strongly
activate the host immune system during in vivo mycobacterial
infections [50,51]. It is possible that early bacterial lysis allows for
the release of significant quantities of mycobacterial proteins and
RNA in host granulomas where it could induce host cell apoptosis
leading to necrotic granulomas, as well as modulate granuloma
environment in favor of bacterial survival. In this context, it was
interesting to observe that mycobacterial RNA fragments affected
the monocyte’s ability to control infection despite stimulating
TNF-a production. TNF-a production is required for both
granuloma formation and bacterial control but alone is not
sufficient [29]. The anti-inflammatory cytokine IL-10 which was
also induced by the RNA fragments could be counteracting TNF-
a. Alternatively, it was recently observed that intranasal delivery of
the synthetic RNA poly-IC, increased bacterial counts in
tuberculosis infected animals by stimulating type-I IFNs [52].
Even though we did not evaluate this family of cytokines, we
Figure 5. The M. tuberculosis RNA’s activity is caspase-8 dependent. A. Flow cytometry demonstrated M. tuberculosis H37Rv RNA (gpRNA)
activated caspase-8. Human monocytes were stimulated with 1 mg/ml of purified M. tuberculosis H37Rv RNA gpRNA (open histogram with dotted
line) or PPD (open histograms with solid line) for 48 h and caspase activity was determined by flow cytometry after staining with FLICA-YVAD-FMK
(caspase-1), FLICA-DEVD-FMK (caspase-3), or FLICA-LETD-FMK (caspase-8). Tissue culture medium without RNA or PPD was used as the control (closed
histogram). B. Stimulation of apoptosis based on annexinV staining was measured for monocytes stimulated with gpRNA or PPD (top histogram) and
when the monocytes were pretreated for 1 h with 10 nM caspase-1 (YVAD-FMK), caspase-3 (DEVD-FMK), or caspase-8 (LETD-FMK) inhibitors (lower
histograms).
doi:10.1371/journal.pone.0029970.g005
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tuberculosis infection when stimulating with mycobacterial instead of
a synthetic RNA.
Multiple studies have evaluated how different types of
macrophage cell death affect mycobacterial survival [11,12,53–
56]. In general, the current dogma is that macrophage apoptosis in
contrast to necrosis, is an innate mechanism to control
mycobacterial infection [55]. Consistent with this, apoptotic
macrophages controlled growth of avirulent mycobacteria,
whereas it was unrestricted for virulent mycobacteria in necrotic
macrophages [57]. Hence, macrophage necrosis was proposed as a
pathogenesis mechanism of virulent mycobacteria [57]. Alterna-
tively, recent mechanistic studies have suggested that inhibition of
apoptosis completion might actually be a cause for mycobacterial-
induced macrophage necrosis [55]. Mitochondrial depolarization,
PS exposure and membrane microdisruptions occurring early
during cell death were similarly observed in macrophages finally
succumbing to necrosis or apoptosis [57–59]. The critical events
tipping the balance to necrosis or apoptosis, as well as bacterial
survival take place further downstream during cell death and
appear to be modulated by the antagonizing effects of prostaglan-
din E2 and lipoxin [57–61]. Similarly, in our studies we identified
that mycobacterial RNA activated early events in monocyte
apoptosis such as PS exposure, TNF-a production and activation
of the initiator caspase-8. In contrast, activation of the effector
caspase-3 was not significant and actually was not involved in PS
exposure. Thus, it remains to be determined whether mycobac-
terial RNA inhibits the downstream completion of apoptosis,
explaining enhanced mycobacterial growth in infected monocytes
exposed to this product. It must also be considered that our
experiments were performed with freshly isolated human mono-
cytes, whereas most of the other studies have been performed with
fully differentiated macrophages. As recently reported by some
members of our group [62], human monocyte phenotype and
susceptibility to mycobacterial-induced cell death is significantly
altered during the differentiation process. Finally, the effect of
mycobacterial RNA could also be synergized by additional
secreted mycobacterial molecules in the macrophage phagosome
[63] or alternatively, as non-differentiated monocytes migrate to
necrotic granulomas harboring extracellular mycobacteria.
A hallmark of M. tuberculosis is the bacterium’s ability to interact
with the host immune response in a manner that allows for its own
survival and at the same time causes active disease in only a
relatively small percentage of the individual it infects. With this
perspective it is not surprising that this pathogen has evolved a
means to take advantage of the eukaryotic mechanism of
programmed cell death. Likewise, the involvement in this process
of a bacterial product that is released or secreted only during active
growth is not surprising. Thus, the continued elucidation of the
exact signaling mechanisms exploited by M. tuberculosis to induce
apoptosis as well as the process the bacterium utilizes to release
RNA fragments will allow further definition of tuberculosis
pathogenesis and the biology of this highly successful pathogen.
Materials and Methods
Growth of M. tuberculosis
To prepare bacilli for monocyte infections, M. tuberculosis
H37Rv (kindly provided by Laboratorio de Micobacterias,
Instituto Nacional de Salud, Bogota, Colombia) was grown as a
pellicle in Middlebrook 7H9 medium (Becton Dickinson, Sparks,
MD) supplemented with glycerol (Promega, Madison, WI), oleic
acid-albumin-dextrose-catalase (OADC) (Becton Dickinson), and
Tween 80 (Becton Dickinson). Cultures were collected and M.
tuberculosis cells washed twice with phosphate buffered saline (PBS).
To disrupt bacterial clumps, M. tuberculosis was suspended in
RPMI-1640 with 20% glycerol and probe sonicated (Model CV33
Sonics Vibra Cell, Newtown, CT) five times at 2.5 W output for
1 min at 4uC. The cell suspensions were stored at 270uC until use.
CFUs were determined prior to monocyte infections by plating
100 mL of serial dilutions of an M. tuberculosis stock on Middlebrook
7H10 agar (Becton Dickinson) supplemented with glycerol and
OADC. Colonies were counted after two weeks of incubation at
37uC.
Isolation of Extracellular RNA
For isolation of biologically active fractions, M. tuberculosis strain
H37Rv was grown in glycerol alanine salts (GAS) medium under
constant rotation in roller bottles for two weeks at 37uC and
culture filtrate (CF) was obtained as previously described [64].
Lyophilized CF was suspended overnight at 4uC at 1 mg/ml
protein concentration in ConcanavalinA (ConA) binding buffer
[65], and passed over a ConA-Sephadex column (Sigma-Aldrich,
St. Louis, MO) to remove mannosylated glycoproteins and
lipoglycans (LM and LAM). The flow-through fraction was
collected, concentrated, and washed three times with 20 mM Tris
(pH 8.1). The CF depleted of mannosylated glycoconjugates
(25 mg) was applied to a 1610 cm column packed with 5 ml of
DEAE-Sepharose (Amersham Biosciences Corporation, Piscat-
away, NJ) equilibrated with Tris 20 mM (pH 8.1). The column
was washed with 20 mM Tris 20 (pH 8.1) and eluted with stepwise
increases (25 to 1000 mM) of NaCl in 20 mM Tris (pH 8.1). Each
fraction was concentrated and dialyzed against 10 mM ammoni-
um bicarbonate, filtered sterilized, lyophilized and stored at
220uC until used.
To prepare highly purified RNA, the material eluted from
DEAE-sepharose with 500–1000 mM NaCl was suspended in
0.1 ml of 10 mM ammonium bicarbonate, 1 mM MgCl2 to a final
concentration of 0.4 mg/ml and digested overnight at 37uC with
RNase-free DNaseI (Sigma-Aldrich), followed by RNase-free
Proteinase K (Sigma-Aldrich) for 8 h at 37uC at a final
concentrations of 0.04 mg/ml. The digested material was
Figure 6. M. tuberculosis H37Rv RNA altered human monocyte’s
ability to control M. tuberculosis infection. CFUs were determined
for human monocytes infected with M. tuberculosis H37Rv and
incubated for four days in the presence of 1 mg/ml of M. tuberculosis
H37Rv CF, purified RNA (gpRNA), or purified RNA digested with
RNaseV1 (gpRNA+RNaseV1). The presence of CF or gpRNA resulted in a
significant increase in CFUs as compared to the untreated infected
monocytes (Control). Data represent the mean 6 SEM of 3 replicates of
the same experiment (*p,0.03).
doi:10.1371/journal.pone.0029970.g006
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alcohol (25:24:1) followed by an equal vol of chloroform:isoamyl
alcohol (24:1). RNA was precipitated from the final aqueous phase
with 0.1 vol of 3 M sodium acetate (pH 5.3) and 2.5 vol of ethanol,
and collected by centrifugation (13,0006 g, 30 min). Final
purification was performed by preparative gel electrophoresis
using a denaturing urea poly-acrylamide gel [26]. RNA prepara-
tions were suspended in PBS, and filter sterilized. The gel purified
RNA was incubated overnight at 37u C with or without 0.1 U/ml
RNaseV1 (Ambion, Austin, TX) and lyophilized. Endotoxin
contamination was determined using the Lymulus Amebocyte
Lysate assay (Bio-Whittaker, Walkersville, Maryland). RNA
concentration was determined by densitometry using Quantity
One software (Version 4.1.1 Bio-Rad, Hercules, CA) after
resolving the M. tuberculosis RNA and standards by denaturing
urea poly-acrylamide gel electrophoresis and staining with
ethidium bromide. To assess for the presence of LAM, samples
(1 mg) were subjected to Western blot analysis using the LAM
specific monoclonal antibody CS-35 as the probe [66].
To evaluate the kinetics of mycobacterial RNA release into the
CF, low passage M. tuberculosis H37Rv was centrifuged at
3,000 rpm and washed three times with medium. Bacterial pellets
were suspended in GAS medium and used to inoculate 400 ml
cultures. CF was collected at different time points of incubation
and processed. Alternatively, CF was precipitated overnight at
220uC with three volumes of ice cold acetone. The precipitated
material was collected by centrifugation and analyzed by SDS-
PAGE [67].
RNA cloning and sequencing
Gel purified RNA was cloned as described by Elbashir and Lau
for small interfering (si)RNA [26,27]. Briefly, the RNA was
dephosphorylated and ligated to the 39adaptor [59 phosphorylated
uuu AAC CGC ATC CTT CTC iT-39; lower case letters
ribonucleotides, capitalized letters deoxyribonucleotides, (Dhar-
macon, Lafayette, CO)]. The ligation products were gel purified,
phosphorylated at the 59 end with T4 polynucleotide kinase (New
England Biolabs, Beverly MA) and ligated to the 59adaptor
sequence [59 TAC TAA TAC GAC TCA CT aaa 39
(Dharmacon)]. Synthesis of cDNA from adaptor-ligated RNA
was accomplished using the Thermoscript kit (Invitrogen) and the
reverse primer (59 GAC TAG CTG GAA TTC AAG GAT GCG
GTT AAA-39). Double stranded DNA was generated by PCR
amplification with the reverse primer, and the forward primer
(59CAG CCA ACG GAA TTC ATA CGA CTC ACT AAA-39).
An aliquot of the PCR products was digested with EcoRI (New
England Biolabs) and ligated to form concatemers that were
resolved by agarose gel electrophoresis and extracted. Overhangs
of poly-A were added with Taq Platinum polymerase in the
presence of dNTPs. The DNA fragments were ligated with pCR
2.1 TOPO vector (Invitrogen), transformed into TOP10 E. coli
(Invitrogen) and individual clones grown for plasmid isolation. The
cloned DNA fragments were sequenced through Macromolecular
Resources Facility (Colorado State University). Plasmid sequences
were analyzed with the Vector NTI software (BioExchange, San
Francisco, CA) to identify the 59 and 39 adaptor sequences, and
the intervening regions were searched against the M. tuberculosis
genome, via BLAST analysis.
Monocyte infection and stimulation
Venous blood (120 ml) was obtained from healthy volunteers
after signing an informed consent form describing the protocol for
human subjects, which was approved by the Ethics Committee of
the Facultad de Medicina, Universidad de Antioquia. The blood
was defibrinated by continuous agitation with glass beads,
centrifuged, and the buffy coat suspended in 3 vol of PBS.
Mononuclear cells were separated on Histopaque, density
1.077 g/ml (Sigma-Aldrich) by centrifugation at 4006g, and cell
viability determined by trypan blue exclusion. Cells were
suspended at 1610
6 cells/ml in RPMI-1640 medium (Gibco
BRL) without antibiotics and supplemented with 0.5% heat-
inactivated autologous serum (AS). The ratio of monocytes was
determined by flow cytometry with anti–CD14-PE staining (clone
M5E2, Becton Dickinson-Pharmingen). CD14+ cells (2610
5/well)
were plated in 48-well flat-bottomed culture plates (Corning,
Corning, NY) for 4 h at 37uC, and non-adherent cells removed by
repeatedly washing with prewarmed PBS with 0.5% AS. RPMI-
1640 supplemented with 10% AS (1 ml) was added to each well.
The number of adherent cells was determined by mechanical
removal and counting in a haemocytometer.
Adhered monocytes were infected with viable M. tuberculosis at a
multiplicity of infection of 5:1 for 4 h. Extracellular bacilli were
removed by repeatedly washing with prewarmed PBS. RPMI-
1640 supplemented with 10% AS (1 ml) was added to each well.
The CF and RNA preparations were added at 1 mg/ml protein or
nucleic acid concentration, respectively. Cultures were incubated
at 37uC, 5% CO2 for 96 h, and the number of viable bacilli
determined by plate counting after lysis of host cells with water
containing 0.1% saponin [12].
For analysis of apoptosis induction or cytokine production the
CF, individual CF fractions, and purified mycobacterial RNA or
rabbit mRNA (Sigma) were added at 1 mg/ml protein or nucleic
acid concentration, respectively. PPD was used as a control at
10 mg/ml. As a control, induction of human monocytes apoptosis
was performed by incubating 10
6 cells with 2 mg/ml of anti-
human CD95 (BD Pharmingen).
Determination of intracellular TNFa and IL-10 by flow
cytometry
Evaluation of intracellular cytokines was based on previous
methods [14]. Briefly, cells were cultured for 18 h with
mycobacterial products at 37uC and 5% CO2. Brefeldin A
(1 mg/ml) was subsequently added and the cultures were incubated
for 6 h. Cells were washed twice with PBS, fixed with 2%
paraformaldehyde in 0.1 M NaH2PO4 for 20 min at room
temperature, and harvested. Intracellular cytokine labeling was
achieved by washing the cells once with permeabilization buffer
[PBS (pH 7.4) containing 1% PHS, 1% BSA, 0.1% sodium azide
and 0.1% saponin], and incubating in 200 ml of permeabilization
buffer containing 2.5 mg mAb anti-TNF-a-FITC and 2.5 mg anti-
IL-10-PE, or IgG2a-FITC and IgG2b-PE as isotype controls for
30 min at 4uC. Cells were washed three times with PBS containing
1% PHS, 1% BSA, and 0.1% sodium azide, pH 7.4. As control for
the intracellular signal, non-permeabilized cells were stained with
the TNF-a and IL-10 specific antibodies. Thereafter cells were
analyzed by flow cytometry with a FACS EPICS XL (Coulter,
Hialeah, FL). The percentage of positive cells and the mean
fluorescence intensity were determined using Windows Multiple
Document Interface 2,8 software (WinMDI, Scrips Research
Institute, La Jolla, CA).
Determination of cell death by flow cytometry using
annexinV and propidium iodide
Cells were cultured for 48 h in the presence of the mycobac-
terial products and incubated for 30 min at RT in darkness with
5 ml of FITC-labeled annexin-V (Molecular Probes, Invitrogen),
10 ml of propidium iodide at 1 mg/ml (ICN Biomedicals, Costa
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analyzed by FACS [11].
To assess whether apoptosis was dependent on TNF-a
signalling, monocytes were incubated for 1 h with purified anti–
TNF-a (MAb11, Becton Dickinson-Pharmingen), followed by the
addition of the different stimuli for 36 h. Thereafter, annexinV
staining was evaluated.
Caspase activation
Caspase activation was measured at 48 h post addition of M.
tuberculosis products to the adhered monocytes. The activation of
caspase-1, 3, and 8 was determined by flow cytometry as previously
described[12].Toevaluatewhethercaspaseactivationwasrequired
for apoptosis, monocytes were incubated with 10 nM of caspase-1
(YVAD.fmk), caspase-3 (DEVD.fmk), or caspase-8 (IEMD.fmk)
specific inhibitors (Sigma-Aldrich) for 1 h prior to the addition of
mycobacterial products. Dimethylsulphoxide and trichloroacetic
acid were also assessed as buffer controls. Exposure of phosphati-
dylserine was then evaluated by staining with annexinV.
Statistical analysis
Experiments were performed a minimum of three independent
times. Data were analyzed with GraphPad Prism, version 4
(GraphPad, San Diego, CA). Comparisons between treatments
were performed by one-way ANOVA. Statistical significance was
tested at p,0.05 as the critical value. Data are presented as the
mean 6 SEM.
Supporting Information
Figures S1 Contig alignments between sequenced RNA
fragments and 16S rRNA, 23S rRNA or tRNA
Asp. Contigs
were generated using Vector NTI software to align sequences from
the cloned RNA fragments with the respective H37Rv sequences
obtained from Tuberculist. Depicted below are the contigs
obtained for 16S rRNA (A), 23S rRNA (B) or tRNA
Asp (C).
(PPTX)
Figure S2 Extracellular mycobacterial RNA fragments
accumulate in the CF with similar kinetics as the rest of
the mycobacterial secretome. Low passage M. tuberculosis
H37Rv was thoroughly washed three times in GAS media by
centrifuging at 3000 rpm and decanting the supernatant. At
different time points (indicated below figure) CF was harvested,
filtered through a 0.2 mm filter and the CF was concentrated by
centrifuging at 3000 rpm in an Amicon with 10 kDa cutoff
membrane. Protein concentration was determined by BCA assay
and 4.8 mg/lane were analyzed by SDS-PAGE plus silver (left gel)
or ethidium bromide (right gel) staining.
(PPTX)
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